z.B. 05/26/2020
z.B. 05/26/2020

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 Juli, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT Test for Managing Sepsis Patients with Elevated Risk of Mortality

01 Juli, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

bioMérieux acquires Hyglos

01 Juni, 2016

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration

31 Mai, 2016

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1   Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients  

bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals

11 April, 2016

Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed

Pioneering Diagnostics